Midgard

Abterra Biosciences

San Diego, CA, United States abterrabio.com From their website, Nov 2026

Work here? Claim this listing

About

Abterra Biosciences provides antibody sequencing and discovery services for researchers and biotech teams. It works on hybridomas, B cells, serum, display libraries, and purified proteins using sequencing, mass spectrometry, and machine learning. The company is based in San Diego, California.

Services

  • Reptor Hybridoma Sequencing

    Next-generation sequencing of hybridomas to recover full-length variable region sequences, detect contaminating minor clones, assess clonality, and read out isotypes.

  • Reptor Bulk B Cell Sequencing

    Next-generation sequencing of sorted B-cell populations and tissues to profile antibody repertoires with error correction and repertoire analysis.

  • Reptor Hit Expansion Sequencing

    Bulk sequencing used to identify relatives of screened antibody hits and expand candidate diversity for discovery campaigns.

  • Reptor Display Library Sequencing

    Next-generation sequencing of display libraries to assess diversity, germline gene representation, and CDR3 diversity.

  • Alicanto Rabbit Antibody Discovery

    Custom rabbit monoclonal antibody discovery from serum with sequence-aware selection and recombinant candidate production.

  • Alicanto Single Domain Antibody Discovery

    Single domain antibody discovery from serum, including llama and alpaca projects, with sequence reporting and candidate validation.

  • Alicanto Human Antibody Discovery

    Human antibody discovery from serum for repertoire analysis and identification of monoclonal antibody candidates.

  • Valens Antibody Protein Sequencing

    Mass spectrometry-based de novo sequencing of monoclonal antibodies directly from protein, recovering full-length heavy and light chain sequences.

    Minimum 50ug of purified monoclonal antibody

3 more services
  • Valens Protein Sequence Confirmation
  • Griffin Polyclonal Antibody Sequencing
  • Alicanto® Rabbit Monoclonal Antibody Discovery
Turnaround
  • 3 weeks
  • 4 weeks
What to send
  • >10k cells per hybridoma
  • 100–5M cells
  • Cryovials and plates
  • DNA or purified phage or yeast
  • 50ug of purified monoclonal antibody
  • 100ug of 90% pure protein
7 more
  • 2.5 mg of antigen for immunization, affinity purification, and ELISA
  • Antibody protein
  • Serum
  • Hybridoma
  • Bulk B cells
  • Display library
  • Target

Capabilities

Assays and studies
  • Antibodies
  • Hybridoma
  • NGS
  • Mass spectrometry
  • Machine learning
  • Error correction
7 more
  • Repertoire analysis
  • Clonality assessment
  • CDR detection
  • Protein sequence confirmation
  • De novo sequencing
  • Next-generation sequencing
  • Proteomic de novo sequencing
Scale and capacity
  • Start from as few as 10,000 cells per hybridoma
  • 100–5M cells for bulk B-cell sequencing
  • Tissue pieces no larger than 1 cm in any dimension
  • Work performed 100% in the USA
  • 4 technologies
  • 9 services
Therapeutic areas
  • Infectious diseases
  • Cancer
  • Autoimmune diseases
  • Oncology
  • Diagnostics

Instruments and platforms

  • Next-generation sequencing platforms
  • Mass spectrometry
  • Next-generation sequencing

Modalities and species

Modalities
  • Antibody
  • Recombinant protein
Species and models
  • Mouse
  • Rat
  • Rabbit
  • Human
  • Transgenics
  • Llama
4 more
  • Alpaca
  • Hybridoma
  • B cells
  • Serum

Industries served

  • Biotech
  • Diagnostics
  • Research
  • Therapeutics
  • Vaccine design
  • Bioanalysis

Company

Type
CRO
Founded
2009
Ownership
Small business, as registered with SAM.gov or stated on their site

Locations

Address
11588 Sorrento Valley Road, Ste 16 San Diego, CA 92121
Serves
USA

Contacts

Public records

Biocom California CRO directory
antibody sequencing, next-generation sequencing, single domain antibody discovery source

Similar labs